申请人:ZENITH EPIGENETICS CORP.
公开号:US20160159801A1
公开(公告)日:2016-06-09
The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.
该发明涉及用于通过结合溴域抑制BET蛋白功能的取代双环化合物,包括这些化合物的制药组合物以及在治疗中使用这些化合物和组合物。